Growth Metrics

Madrigal Pharmaceuticals (MDGL) Shares Issued (2019 - 2025)

Historic Shares Issued for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to $17.7 million.

  • Madrigal Pharmaceuticals' Shares Issued changed N/A to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 9562.23%. This contributed to the annual value of $397.5 million for FY2024, which is 4705.84% up from last year.
  • According to the latest figures from Q3 2025, Madrigal Pharmaceuticals' Shares Issued is $17.7 million.
  • Madrigal Pharmaceuticals' 5-year Shares Issued high stood at $311.6 million for Q1 2024, and its period low was -$23000.0 during Q4 2024.
  • Over the past 5 years, Madrigal Pharmaceuticals' median Shares Issued value was $19.0 million (recorded in 2021), while the average stood at $74.8 million.
  • Within the past 5 years, the most significant YoY rise in Madrigal Pharmaceuticals' Shares Issued was 164027.26% (2024), while the steepest drop was 10000.94% (2024).
  • Over the past 5 years, Madrigal Pharmaceuticals' Shares Issued (Quarter) stood at $19.0 million in 2021, then skyrocketed by 1247.09% to $255.4 million in 2022, then dropped by 4.37% to $244.2 million in 2023, then crashed by 100.01% to -$23000.0 in 2024, then skyrocketed by 77208.7% to $17.7 million in 2025.
  • Its Shares Issued stands at $17.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $8.6 million for Q1 2025.